Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emory University
With
Forest Laboratories
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or post-menopausal females aged 18-80 years.
Subjects self-identified as black or African-American.
Diagnosis of hypertension.
Patients on current anti-hypertensive therapy that does not include beta blockade should have BP \>135/85.
Patients on anti-hypertensive therapy including beta blockers will have their beta blockers discontinued gradually over 2 weeks before enrolment.
Concomitant therapy: Patients will be allowed to be on concomitant therapy with aspirin, statins, thiazide diuretics, calcium antagonists (for treatment of hypertension), clonidine, or vasodilators. Patients will be on stable medical therapy for at least 2 months before recruitment. Patients with previous treatment with beta adrenergic blockers (metoprolol, propranolol, atenolol, and labetalol) will also be eligible to participate, but will be randomized to the study beta blocker.
You may not be if
Initiation or change in dose of statin or other anti-hypertensive therapy within 2 months before the study
Inability to return to Emory for follow-up testing
Age \< 21 or \>80 years
Premenopausal females with potential for pregnancy
Acute infection in previous 2 weeks
On angiotensin antagonists (ACE inhibitors or ARBs)
